News

Medical Marijuana, Inc. Subsidiary Kannaway® Recognizes Second Brand Ambassador in Company History to Achieve International Director Title

August 4, 2017

Kannaway Logo hemp

SAN DIEGO, Aug. 4, 2017 — Medical Marijuana, Inc. (OTC: MJNA) announced today that its subsidiary Kannaway, LLC, the first hemp lifestyle network to offer cannabidiol (CBD) hemp botanical products, is recognizing Randy Schroeder as its second Brand Ambassador in Company history to reach the rank of

Kannalife Sciences Participates in 27th Annual International Cannabinoid Research Society (ICRS) Symposium

July 6, 2017

general-hemp-blog-images-12-08-16-ver1

Company Presents Science Behind Mechanism of Action of CBD and its Own Patented CBD-derived Molecule KLS-13019 NEW YORK, July 5, 2017 /PRNewswire/ — Kannalife Sciences, Inc. (“Kannalife”), a bio-pharmaceutical and phyto-medical company, announced today that it presented its findings at the 27th Annual ICRS Symposium on

Medical Marijuana, Inc. Clarifies Operations Unaffected by White House Statements Hinting at Recreational Marijuana Crackdown

March 1, 2017

general_hemp_blog_images_03-01-17_ver1 (1)

SAN DIEGO, March 1, 2017 — Medical Marijuana, Inc. (OTC:MJNA), the first publicly traded cannabis company in the United States, is reassuring customers, shareholders, and the public that the company’s operations in the federally legal hemp cannabidiol (CBD) market are unaffected by

Medical Marijuana, Inc. CEO to Speak on Nutritional and Therapuetic Benefits of Hemp at 3rd Annual Cannabis World Congress and Business Expo

June 9, 2016

iStock_000034925370_Small

RSHO Advocate Penny Howard to Share Story on How Her Fight to Save Daughter Harper Helped Legalize New Markets and Change Lives in Latin America SAN DIEGO, CA – June 9, 2016 – Medical Marijuana, Inc. (OTC: MJNA) today announced that at

Medical Marijuana, Inc. and Kannalife Sciences, Inc. Announce Joint Effort to Raise Awareness for CTE Research

December 22, 2015

Screen Shot 2015-12-22 at 10.31.38 AM

www.treatCTE.org Opens Opportunity for Research and Development of Grassroots Fundraiser “Show Your Green” PSA Drives Awareness Campaign with Former NFL Star Marvin Washington NEW YORK – December 22, 2015 – Medical Marijuana, Inc. (OTC Pink: MJNA) is proud to announce

Medical Marijuana, Inc.’s Portfolio Company KannaLife’s Spokesman, Ex-NFL Star Marvin Washington to Appear on ESPN’s Outside the Lines

December 18, 2015

Screen Shot 2015-12-18 at 11.29.49 AM

Former Super Bowl Champ to Appear on ESPN Panel Focused on Will Smith’s New Film Concussion, Discussing Traumatic Brain Injuries and Web Site www.TreatCTE.org NEW YORK, Dec. 18, 2015 (GLOBE NEWSWIRE) – Medical Marijuana, Inc. (OTC Pink:MJNA) is proud to

Fox News: Will Pot Save NFL?

November 5, 2015

iStock_000011199130_Small

KannaLife was featured on Sports Court as Tamara Holder and Marvin Washington discussed the new push to swap pain pills with pot to treat NFL injuries. “He’s seen guys leave the game addicted to pharmaceuticals and so have I, but

The Man Guide: The Case For Cannabidoil

October 8, 2015

cannabis_01_bgiu

KannaLife Sciences was featured in an article by the MAN guide about how the same government that’s waging war against marijuana also has a patent on its health benefits. The team had examined cannabinoids—chemicals unique to the cannabis plant—and found that

Bumbbells and Dragons: League of Concussions: The NFL and Head Injuries

September 22, 2015

iStock_000026427695_Small

KannaLife Sciences was featured in an article by Bumbbells and Dragons about a new development in treating brain injuries. “We were lucky enough to sit down with former NFL defensive end and Super Bowl XXXIII champion, Marvin Washington to talk

Medical Marijuana, Inc’s Portfolio Investment Company Kannalife Sciences Announces Publication of Its Global PCT Patent Covering Cannabidiol-like Neuroprotective Agents

August 19, 2015

kannalife270

Milestone Accomplishment to Lead KSI to Further Patents and IP SAN DIEGO, Aug. 14, 2015 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. portfolio investment company Kannalife Sciences, Inc. has announced the publication of its global WIPO/PCT Patent WO2015/106108A2 – ‘Novel Functionalized